Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence

Neurochemical Research

Volumn 21, Issue 11, 1996, Pages 1347-1351

  Crain, Stanley M ^a   Shen, Ke Fei ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Excitatory vs inhibitory opioid receptor functions; nociceptive types of sensory neurons; opioid modulation of action potentials; tissue culture models of tolerance dependence

Indexed keywords

ADENYLATE CYCLASE; BETA ENDORPHIN; BIPHALIN; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DELTA OPIATE RECEPTOR; DIPRENORPHINE; DYNORPHIN; ENDORPHIN; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ETORPHINE; GANGLIOSIDE GM1; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTREXONE; NEUROTRANSMITTER; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST;

ACTION POTENTIAL; ANALGESIA; ANTINOCICEPTION; ARTICLE; CALCIUM TRANSPORT; DOSE RESPONSE; DRUG POTENCY; DRUG TOLERANCE; ION CONDUCTANCE; NEUROTRANSMITTER RELEASE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; SPINAL GANGLION; TAIL FLICK TEST; WITHDRAWAL SYNDROME;

EID: 0029957393     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02532375     Document Type: Article

References (59)

1. Crain, S. M. 1966. Development of "organotypic" bioelectric activities in central nervous tissues during maturation in culture. Int. Rev. Neurobiol. 9:1-43.
2. Crain, S. M. 1976. Neurophysiologic Studies in Tissue Culture. Raven Press, New York.
3. Crain, S. M. 1983. Role of CNS target cues in formation of specific afferent synaptic connections in organotypic cultures. Pages 1-32, in Pfeiffer, S. E. (ed.), Neuroscience Approached through Cell Culture, Vol II, CRC Press, Boca Raton, FL.
4. Crain, S. M., Peterson, E. R., Crain, B., and Simon, E. J. 1977. Selective opiate depression of sensory-evoked synaptic networks in dorsal-horn region of spinal cord cultures. Brain Res. 133:162-166.
5. Crain, S. M., Crain, B., Peterson, E. R., and Simon, E. J. 1978. Selective depression by opioid peptides of sensory-evoked dorsal-horn network responses in organized spinal cord cultures. Brain Res. 157:196-201.
6. Crain, S. M., Crain, B., Finnigan, T., and Simon, E. J. 1979. Development of tolerance to opiates and opioid peptides in organotypic cultures of mouse spinal cord. Life Sci. 25:1797-1802.
7. Killer, J. M., Simon, E. J., Crain, S. M., and Peterson, E. R. 1978. Opiate receptors in cultures of fetal mouse dorsal root ganglion (DRG) and spinal cord: Predominance in DRG neuntes. Brain Res. 145:396-400.
8. Crain, S. M. 1984. Tissue culture models for analyses of opioid analgesia, tolerance and plasticity. Pages 260-292, In Sharp, C. (ed.) NIDA Research Monograph: Mechanisms of Tolerance and Dependence (ADM 84-1330), U.S. Govt. Printing Office, Washington, D.C.
9. Crain, S. M., and Peterson, E. R. 1974. Enhanced afferent synaptic function in fetal mouse spinal cord-sensory ganglion explants following NGF-induced ganglion hypertrophy. Brain Res. 79:145-152.
10. Crain, S. M., and Peterson, E. R. 1982. Selective innervation of target regions within fetal mouse spinal cord and medulla explants by isolated dorsal root ganglion in organotypic co-cultures. Devel. Brain Res. 2:341-362.
11. Shen, K.-F., and Crain, S. M. 1994. Nerve growth factor rapidly prolongs the action potential of mature sensory neurons in culture and this effect requires activation of Gs-coupled excitatory kappa opioid receptors on these cells. J. Neurosci. 14:5570-5579.
12. Crain, S. M., and Shen, K.-F. 1990. Opioids can evoke direct receptor- mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11:77-81.
13. Shen, K.-F., and Crain, S. M. 1989. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491:227-242.
14. Chalazonitis, A., and Crain, S. M. 1986. Maturation of opioid sensitivity of fetal mouse dorsal-root ganglion neuron perikarya in organotypic cultures:regulation by spinal cord. Neurosci. 17: 1181-1198.
15. Mudge, A. W., Leeman, S. E., and Fischbach, G. D. 1979. Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc. Natl. Acad. Sci. USA. 76:526-530.
16. North, R. A. 1986. Opioid receptor types and membrane ion channels. Trends Neurosci. 9:114-117.
17. Werz, M. A., and Macdonald, R. L. 1983. Opioid peptides with differential affinity for mu- and delta-receptors decrease sensory neuron calcium-dependent action potentials. J. Pharmacol. Exp. Ther. 227:394-402.
18. Werz, M. A., and Macdonald, R. L. 1985. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium dependent action potential duration. J. Pharmacol. Exp. Ther. 234: 49-56.
19. Chen, G.-G., Chalazonitis, A., Shen, K.-F., and Crain, S. M. 1988. Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neuron in dissociated cell culture. Brain Res. 462:372-377.
20. Crain, S. M., Shen, K.-F., and Chalazonitis, A. 1988. Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures. Brain Res. 455:99-109.
21. Cruciani, R. A., Dvorkin, B., Morris, S. A., Crain, S. M., and Makman, M. H. 1993. Direct coupling of opioid receptors to both Gs and Gi proteins in F-11 neuroblastoma X sensory neuron hybrid cells. Proc. Natl. Acad. Sci. USA. 90:3019-3023.
22. + channels in sensory ganglion neurons. Brain Res. 558:166-170.
23. Shen, K.-F., and Crain, S. M. 1990. Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors. Brain Res. 525:225-231.
24. Gross, R. A., Moises, H. C., Uhler, M. D., and Macdonald, R. L. 1990. Dynorphin A and CAMP-dependent protein kinase independently regulate neuronal calcium currents. Proc. Natl. Acad. Sci. USA. 87:7025-7029.
25. Crain, S. M., Crain, B., and Makman, M. H. 1987. Pertussis toxin blocks depressant effects of opioid, monoaminergic and muscarinic agonists on dorsal-horn network responses in spinal cord-ganglion cultures. Brain Res. 400:185-190.
26. Miyake, M. J., Christie, M. J., and North, R. A. 1989. Single potassium channels opened by opioids in rat locus ceruleus neurons. Proc. Natl. Acad. Sci. USA. 86:3419-3422.
27. Fujimoto, J. M., Arts, K. S., Rady, J. J. and Tseng, L. F. 1990. Spinal dynorphin A(1-17): possible mediation of antianalgesic action. Neuropharmacol. 29:609-617.
28. Crain, S. M., and Shen, K.-F. 1992. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res. 575:13-24.
29. Suarez-Roca, H., and Maixner, W. 1993. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J. Pharmacol. Exp. Therap. 264:648-653.
30. Crain, S. M., and Shen, K.-F. 1992. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition. J. Pharmacol. Exp. Ther. 260:182-186.
31. Shen, K.-F., and Crain, S. M. 1992. Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid dependence without tolerance. Brain Res. 597:74-83.
32. Nestler, E. J. 1992. Molecular mechanisms of drug addiction. J. Neurosci. 12:2439-2450.
33. Terwilliger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M., and Nestler, E. J. 1991. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:100-110.
34. Crain, S. M., and Shen, K.-F. 1995. Etorphine elicits unique inhibitory-agonist and excitatory-antagonist actions at opioid receptors on sensory neurons: New rationale for improved clinical analgesia and treatment of opiate addiction. Pages 234-268. in Repaka, R. S. & Sorer, H. (eds.), Discovery of Novel Opioid Medications, NIDA Monograph, U.S. Govt. Print. Office, Washington, D.C.
35. Bentley, K. W., and Hardy, D. G. 1963. New potent analgesics in the morphine series. Proc. Chem. Soc. p. 220.
36. Blane, G. F., Boura, A. L. A., Fitzgerald, A. E. and Lister, R. E. 1967. Actions of etorphine hydrochloride (M99): A potent morphine-like agent. Brit. J. Pharmacol. Chemother. 30:11-22.
37. Bentley, K. W., and Hardy D. G. 1967. Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-Ethenotetrahydrooripavine series and derived analogs of n-allylnormorphine and -norcodeine. J. Amer. Chem. Soc. 89:3281-3292.
38. Shen, K.-F., and Crain, S. M. 1994. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence. Brain Res. 636:286-297.
39. Lange, D. G., Fujimoto, J. M., Fuhrman-Lane, C. L., and Wang, R. I. H. 1980. Unidirectional non-cross tolerance to etorphine in morphine-tolerant mice and role of the blood-brain barrier. Toxicol. Applied Pharmacol. 54:177-186.
40. Xu, J. Y., Fujimoto, J. M., and Tseng, L. F. 1992. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse. J. Pharmacol. Exp. Therap. 263:246-252.
41. Qin, B.-Y. 1993. Research advances of dihydroetorphine: from analgesia to detoxification. New Drugs and Clin. Remedies 12: 119-123.
42. Qin, B.-Y. 1994. The application of dihydroetorphine to detoxification of heroin addicts. Regulatory Peptides (Suppl. 1) 50:581-S82.
43. Wang, S. F., Yan, D. K., Yang, Z., and Qin, B. Y. 1992. Clinical investigation on detoxification of heroin addiction with dihydroetorphine hydrochloride. Chin J. Clin. Pharmacol. 8:106-112.
44. Horan, P. J., Mattia, A., Bilsky, E. J., Weber, S., Davis, T. P., Yamamura, H. I., Malatynska, E., Appleyard, S. M., Slaninova, J., Misicka, A., Lipkowski, A. W., Hruby, V. J., and Porreca, F. 1993. Antinociceptive profile of biphalin, a dimeric enkephalin analog. J. Pharmacol. Exp. Therap. 26:1446-1454.
45. Shen, K.-F., and Crain, S. M. 1995. Biphalin, an enkephalin analog with unexpectedly high antinociceptive potency and low dependence liability in vivo, selectively antagonizes excitatory opioid receptor functions of sensory neurons in culture. Brain Res. 701:158-166.
46. Crain, S. M., and Shen, K.-F. 1995. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc. Natl. Acad. Sci. USA. 92:10540-10544.
47. Shen, K.-F., and Crain, S. M. 1995. Specific N- or C-terminus modified dynorphin and β-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists. Brain Res. 673:30-38.
48. Crain, S. M., and Shen, K.-F. 1995. Chronic morphine-treated sensory ganglion neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: an in vitro model of "protracted opioid dependence". Brain Res. 694:103-110.
49. Crain, S. M., and Shen, K.-F. 1995. Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists. U.S. Patent #5,472,943, US Patent Office, Washington, DC.
50. Uhl, G. R., Childers, S., and Pasternak, G. 1994. An opiate-receptor gene family reunion. Trends Neurophysiol. 17:89-93.
51. + conductance of DRG neurons and neuroblastoma X DRG neuron hybrid F11 cells. Brain Res. 696: 97-105.
52. 2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem. 267: 15759-15801.
53. 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell 67:723-730.
54. 2- adrenergic receptors. Mol. Brain Res. 28:72-80.
55. Wu, G., Lu, Z., and Ledeen, R. W. 1995. GM1 conversion of a cloned δ opioid receptor from inhibitor to stimulator of adenyl cyclase. J. Neurochem. 64:8104.
56. Shen, K.-F., and Crain, S. M. 1992. Cholera-toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions. Brain Res. 531:1-7.
57. Shen, K.-F., Crain, S. M., and Ledeen, R. W. 1991. Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential. Brain Res. 559:130-138.
58. + currents. J. Neurosci. Res. 42:493-503.
59. Crain, S. M. and Shen, K.-F. 1996. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells. Brain Res. (in press).